Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients.
Gürsoy
M
M
Başkent University Faculty of Medicine, Departments of Gastroenterology, Nephrology, and General Surgery, Ankara, Turkey.
Köksal
R
R
Karavelioğlu
D
D
Colak
T
T
Gür
G
G
Ozdemir
N
N
Boyacioğlu
S
S
Bilgin
N
N
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006085:Graft Survival; D006526:Hepatitis C / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D011300:Preoperative Care; D016019:Survival Analysis; D014184:Transplantation, Homologous
D000998:Antiviral Agents; D016898:Interferon-alpha